ASHP continues to foster concrete improvements in pharmacy practice and in the therapeutic use of drugs with its annual compilation of ASHP guidance documents: ASHP Best Practices. These guidance documents have stimulated improvements in pharmacy practice and operations, influenced accreditation standards, laws, and regulations (both in the United States and in other countries), and contributed to an awareness among consumers and policymakers of the vital patient care role of pharmacists.
The Most Comprehensive Set of Quality Guidelines Available to the Pharmacy Profession
The most comprehensive set of quality guidelines available to the pharmacy profession. ASHP continues to foster concrete improvements in pharmacy practice and in the therapeutic use of drugs with its annual compilation of ASHP guidance documents that provide ongoing advice to practitioners and health systems.
New or revised material in this edition includes:
ASHP Statement on the Use of Artificial Intelligence in Pharmacy
ASHP Guidelines on Emergency Medicine Pharmacist Services
ASHP Guidelines on Medication-Use Evaluation
ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System
ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder
ASHP Therapeutic Position Statement on Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus Aureus Infections: A Revised Consensus Guideline and Review
Position Paper on Critical Care Pharmacy Services: 2020 Update
Principles for COVID-19 Vaccine Distribution, Allocation, and Mass Immunization
ASHP is the author of the publication.
Bruce Hawkins is Editor, Best Practices, and Director, Policy Development Operations, Office of Practice Advancement, ASHP.